Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 363404, 9 pages
http://dx.doi.org/10.1155/2014/363404
Research Article

Enhanced Oral Bioavailability of Efavirenz by Solid Lipid Nanoparticles: In Vitro Drug Release and Pharmacokinetics Studies

1Department of Pharmaceutics, I.T.S. Paramedical College (Pharmacy), Muradnagar, Ghaziabad 201206, India
2Department of Pharmacognosy & Phytochemistry, Jamia Hamdard, New Delhi 110062, India

Received 24 February 2014; Revised 6 April 2014; Accepted 10 April 2014; Published 21 May 2014

Academic Editor: Mehrdad Hamidi

Copyright © 2014 Praveen Kumar Gaur et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. K. Sahoo and V. Labhasetwar, Eds., Nanoparticles Interface: An Important Determinant in nanoparticle-Mediated Drug/Gene Delivery. Nanoparticle Technology for Drug Delivery, Taylor & Francis, New York, NY, USA, 2006.
  2. M. S. Falzarano, C. Passarelli, and E. Bassi, “Biodistribution and molecular studies on orally administered nanoparticle-AON complexes encapsulated with alginate aiming at inducing dystrophin rescue in mdx mice,” BioMed Research International, vol. 2013, Article ID 527418, 13 pages, 2013. View at Publisher · View at Google Scholar
  3. P. Gaur, S. Purohit, and S. Mishra, “Solid lipid nanoparticles of guggul lipid as drug carrier for transdermal drug delivery,” BioMed Research International, vol. 2013, Article ID 750690, 10 pages, 2013. View at Publisher · View at Google Scholar
  4. P. K. Gaur, S. Mishra, and V. Aeri, “Formulation and evaluation of guggul lipid nanovesicles for transdermal delivery of aceclofenac,” The Scientific World Journal, vol. 2014, Article ID 534210, 10 pages, 2014. View at Publisher · View at Google Scholar
  5. S. P. Vyas and R. K. Khar, Eds., Nanoparticles. Targeted and Controlled Drug Delivery—Novel Carrier Systems, CBS, New Delhi, India, 2002.
  6. P. K. Gaur, S. Purohit, Y. Kumar, S. Mishra, and A. Bhandari, “Preparation, characterization and permeation studies of a nanovesicular system containing diclofenac for transdermal delivery,” Pharmaceutical Development and Technology, vol. 19, no. 1, pp. 48–54, 2014. View at Google Scholar
  7. S. Morel, E. Ugazio, R. Cavalli, and M. R. Gasco, “Thymopentin in solid lipid nanoparticles,” International Journal of Pharmaceutics, vol. 132, pp. 259–261, 1996. View at Google Scholar
  8. J. D. Kingsley, H. Dou, J. Morehead, B. Rabinow, H. E. Gendelman, and C. J. Destache, “Nanotechnology: a focus on nanoparticles as a drug delivery system,” Journal of Neuroimmune Pharmacology, vol. 1, no. 3, pp. 340–350, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. A. A. Attama, S. Reichl, and C. C. Müller-Goymann, “Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct,” International Journal of Pharmaceutics, vol. 355, no. 1-2, pp. 307–313, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Bhaskar, J. Anbu, V. Ravichandiran, V. Venkateswarlu, and Y. M. Rao, “Lipid nanoparticles for transdermal delivery of flurbiprofen: formulation, in vitro, ex vivo and in vivo studies,” Lipids in Health and Disease, vol. 8, article 6, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. S. A. Chime, A. A. Attama, P. F. Builders, and G. C. Onunkwo, “Sustained-release diclofenac potassium-loaded solid lipid microparticle based on solidified reverse micellar solution: in vitro and in vivo evaluation,” Journal of Microencapsulation, vol. 30, no. 4, pp. 335–345, 2013. View at Publisher · View at Google Scholar
  12. D. A. Chiappetta, C. Hocht, C. Taira, and A. Sosnik, “Efavirenz-loaded polymeric micelles for pediatric anti-HIV pharmacotherapy with significantly higher oral bioavailability,” Nanomedicine, vol. 5, no. 1, pp. 11–23, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Baert, L. Schueller, Y. Tardy et al., “Development of an implantable infusion pump for sustained anti-HIV drug administration,” International Journal of Pharmaceutics, vol. 355, no. 1-2, pp. 38–44, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Schwarz, W. Mehnert, J. S. Lucks, and R. H. Muller, “Solid lipid nanopar-ticles (SLN) for controlled drug delivery. I. Production, characteriza-tion and sterilization,” Journal of Controlled Release, vol. 30, pp. 83–96, 1994. View at Google Scholar
  15. P. K. Gaur, S. Purohit, and S. Mishra, “Development of aceclofenac nanovesicular system using biomaterial for transdermal delivery: physical characterization, ex vivo, in vivo, and anti-inflammatory studies,” Journal of Biomaterials Science, Polymer Edition, vol. 24, no. 18, pp. 2126–2141, 2013. View at Google Scholar
  16. P. K. Gaur, S. Purohit, Y. Kumar, S. Mishra, and A. Bhandari, “Ceramide-2 nanovesicles for effective transdermal delivery: development, characterization and pharmacokinetic evaluation,” Drug Development and Industrial Pharmacy, vol. 40, no. 4, pp. 568–576, 2014. View at Publisher · View at Google Scholar
  17. T. K. Kwon, K. B. Lim, and J.-C. Kim, “Solid lipid nanoparticles coated with silk fibroin,” Journal of Industrial and Engineering Chemistry, vol. 17, no. 1, pp. 10–13, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Liu, S. Jiang, H. Shen et al., “Diclofenac sodium-loaded solid lipid nanoparticles prepared by emulsion/solvent evaporation method,” Journal of Nanoparticle Research, vol. 13, no. 6, pp. 2375–2386, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Nemmar, J. A. Holme, I. Rosas, P. E. Schwarze, and E. Alfaro-Moreno, “Recent advances in particulate matter and nanoparticle toxicology: a review of the in vivo and in vitro studies,” BioMed Research International, vol. 2013, Article ID 279371, 22 pages, 2013. View at Publisher · View at Google Scholar
  20. H. Reithmeier, J. Herrmann, and A. Göpferich, “Development and characterization of lipid microparticles as a drug carrier for somatostatin,” International Journal of Pharmaceutics, vol. 218, no. 1-2, pp. 133–143, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Ishida, Y. Takanashi, H. Doi, I. Yamamoto, and H. Kiwada, “Encapsulation of an antivasospastic drug, fasudil, into liposomes, and in vitro stability of the fasudil-loaded liposomes,” International Journal of Pharmaceutics, vol. 232, no. 1-2, pp. 59–67, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Dragicevic-Curic, D. Scheglmann, V. Albrecht, and A. Fahr, “Temoporfin-loaded invasomes: development, characterization and in vitro skin penetration studies,” Journal of Controlled Release, vol. 127, no. 1, pp. 59–69, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Jukanti, S. Sheela, S. Bandari, and P. R. Veerareddy, “Enhanced bioavailability of exemestane via proliposomes based transdermal delivery,” Journal of Pharmaceutical Sciences, vol. 100, no. 8, pp. 3208–3222, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. G. V. Patel, V. B. Patel, A. Pathak, and S. J. Rajput, “Nanosuspension of efavirenz for improved oral bioavailability: formulation optimization, in vitro, in situ and in vivo evaluation,” Drug Development and Industrial Pharmacy, vol. 40, no. 1, pp. 80–91, 2014. View at Google Scholar
  25. T. Helgason, T. S. Awad, K. Kristbergsson, D. J. McClements, and J. Weiss, “Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN),” Journal of Colloid and Interface Science, vol. 334, no. 1, pp. 75–81, 2009. View at Publisher · View at Google Scholar · View at Scopus